A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED [prednisolone-metasulfobenzoate-sodium] in the Treatment of Moderate Acute Ulcerative Colitis

Trial Profile

A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED [prednisolone-metasulfobenzoate-sodium] in the Treatment of Moderate Acute Ulcerative Colitis

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Apr 2017

At a glance

  • Drugs Prednisolone metasulfobenzoate sodium (Primary) ; Prednisolone
  • Indications Ulcerative colitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Alizyme
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Nov 2012 Planned number of patients changed from 796 to 890.
    • 25 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top